title: Persistent lactic acidosis after chronic topical application of silver sulfadiazine in a pediatric burn patient: a review of the literature.
abstract: A 3-year old male who sustained 2(nd) and 3(rd) degree burns that covered approximately 60% TBSA presented to a large adult and pediatric verified burn center. On hospital day (HD) 26 of his stay, Candida fungemia was identified by blood culture, delaying operative management until HD 47. On HD 47, after his first operative intervention, the patient developed a persistent metabolic and lactic acidosis. On HD 66, a search for a cause of his osmol gap of 56 mOsm/kg revealed a potential source-propylene glycol. Previous studies have implicated the propylene glycol emulsifier in the silver sulfadiazine that was being applied to his skin as a rare cause of lactic acidosis in severely burned patients. Within 24 hours of stopping the silver sulfadiazine therapy, his lactic acidosis and osmol gap resolved; within 72 hours his metabolic acidosis resolved. Silver sulfadiazine is commonly used adjunct therapy in the treatment of 2(nd) and 3(rd) degree burns and generally has few adverse reactions. The absorption of propylene glycol systemically can rarely occur when applied to extensive burns, presumably due to the disruption of the skin barrier; the half-life of PG is 10 hours and can be prolonged with renal disease because ~50% of the sulfadiazine is excreted in the urine unchanged. When propylene glycol is present systemically, it is metabolized to lactic acid in the liver, which can cause a lactic acidosis. Several commonly used drugs also use propylene glycol as an emulsifier, including IV preparations of lorazepam, pentobarbital, phenobarbital, and phenytoin. In all of these clinical scenarios, including severe burn patients that are being treated with silver sulfadiazine, both lactic acid and propylene glycol levels should be measured to monitor for this rare, potentially serious co-morbidity.
authors: Department of Pathology & Laboratory Medicine, University of North Carolina Chapel Hill, NC 27599, USA.
authors: Monte S
authors: MS
authors: Willis
authors: Bruce A
authors: BA
authors: Cairns
authors: Ashley
authors: A
authors: Purdy
authors: Andrey V
authors: AV
authors: Bortsov
authors: Samuel W
authors: SW
authors: Jones
authors: Shiara M
authors: SM
authors: Ortiz-Pujols
authors: Tina M Schade
authors: TM
authors: Willis
authors: Benny L
authors: BL
authors: Joyner
keywords: Burn; hyperosmolality; metabolic acidosis; propylene glycol; silver sulfadiazine
references: Chest. 2005 Sep;128(3):1674-81
references: 16162774
references: Am J Kidney Dis. 1997 Jul;30(1):134-9
references: 9214414
references: Crit Care Med. 2004 Aug;32(8):1709-14
references: 15286548
references: Am J Clin Pathol. 1979 Oct;72(4):633-6
references: 495568
references: Qual Saf Health Care. 2003 Dec;12(6):458-64
references: 14645763
references: Acta Chir Scand. 1970;136(8):741-51
references: 5518153
references: Pharmacotherapy. 2001 Sep;21(9):1140-4
references: 11560204
references: Acta Paediatr. 1998 Nov;87(11):1195-6
references: 9846924
references: N Engl J Med. 2002 Apr 18;346(16):1253-4
references: 11961161
references: Clin Chim Acta. 2011 Jul 15;412(15-16):1441-6
references: 21549689
references: Arch Dis Child. 2010 Dec;95(12):1054-8
references: 20959360
references: Pharmacotherapy. 2010 Feb;30(2):219
references: 20099997
references: N Engl J Med. 2000 Sep 14;343(11):815
references: 10991709
references: Ann Plast Surg. 1985 May;14(5):407-19
references: 4083697
references: Arch Intern Med. 1991 Nov;151(11):2297-8
references: 1953236
references: J Trauma. 1980 Mar;20(3):223-8
references: 7359597
references: Qual Saf Health Care. 2008 Apr;17(2):137-45
references: 18385409
references: Neurocrit Care. 2008;9(1):122-4
references: 18270846
references: Semin Dial. 2007 May-Jun;20(3):217-9
references: 17555487
references: BMJ Qual Saf. 2012 Dec;21(12):1019-26
references: 22822243
references: Clin Chem Lab Med. 2011 Nov;49(11):1837-43
references: 21801029
references: Am J Kidney Dis. 2011 Sep;58(3):480-4
references: 21794966
references: Intensive Care Med. 1988;14(3):221-6
references: 3132492
references: JAMA. 1985 Mar 15;253(11):1606-9
references: 3974044
references: Am Heart J. 1967 Oct;74(4):523-9
references: 6047775
references: Nat Clin Pract Nephrol. 2007 Sep;3(9):515-20
references: 17717564
references: Intensive Care Med. 2002 Jan;28(1):81-4
references: 11819005
references: Int J Health Care Qual Assur. 2010;23(1):59-71
references: 21387864
references: BMJ Qual Saf. 2011 Jan;20(1):46-51
references: 21228075
references: Burns Incl Therm Inj. 1983 Sep;10(1):9-12
references: 6640389
references: Ann Pharmacother. 1997 May;31(5):647-8
references: 9161670